Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice
Open accessThe DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.
Abstract
Asthma is a common chronic pulmonary inflammatory disease, featured with mucus hyper-secretion in the airway. Recent studies found that glucagon like peptide-1 (GLP-1) analogs, including liraglutide and exenatide, possessed a potent anti-inflammatory property through a protein kinase A (PKA)-dependent signaling pathway. Therefore, the aim of current study was to investigate the value of GLP-1 analog therapy liraglutide in airway inflammation and mucus secretion in a murine model of ovalbumin (OVA)-induced asthma, and its underlying molecular mechanism. In our study, BALB/c mice were sensitized and challenged by OVA to induce chronic asthma. Pathological alterations, the number of cells and the content of inflammatory mediators in bronchoalveolar lavage fluid (BALF), and mucus secretion were observed and measured. In addition, the mRNA and protein expression of E-selectin and MUC5AC were analyzed by qPCR and Western blotting. Then, the phosphorylation of PKA and nuclear factor-κB (NF-κB) p65 were also measured by Western blotting. Further, NF-κB p65 DNA binding activity was detected by ELISA. OVA-induced airway inflammation, airway mucus hyper-secretion, the up-regulation of E-selectin and MUC5AC were remarkably inhibited by GLP-1 in mice (all p < 0.01). Then, we also found that OVA-reduced phosphorylation of PKA, and OVA-enhanced NF-κB p65 activation and NF-κB p65 DNA binding activity were markedly improved by GLP-1 (all p < 0.01). Furthermore, our data also figured out that these effects of GLP-1 were largely abrogated by the PKA inhibitor H-89 (all p < 0.01). Taken together, our results suggest that OVA-induced asthma were potently ameliorated by GLP-1 possibly through a PKA-dependent inactivation of NF-κB in mice, indicating that GLP-1 analogs may be considered an effective and safe drug for the potential treatment of asthma in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Liraglutide (2 mg/kg) reduced immune cell infiltration and protein expression of E-selectin, TNF-α, IL-4, IL-5, and IL-13 in the lung tissue or bronchoalveolar lavage fluid in an ovalbumin-induced chronic asthma model.”
From Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control (2016) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hattori, Y., Jojima, T., Tomizawa, A., Satoh, H., Hattori, S., Kasai, K., & Hayashi, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1831-8 · Cited by 183
RetractedThe prevalence of severe refractory asthma
Hekking, P.-P. W., Wener, R. R., Amelink, M., Zwinderman, A. H., Bouvy, M. L., & Bel, E. H. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.042 · Cited by 813
Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor
Bullock, B. P., Heller, R. S., & Habener, J. F. (1996) · Endocrinology · doi:10.1210/en.137.7.2968 · Cited by 618 · cited 1×
“Therefore, these findings, in consistent with the previous studies, indicated that GLP-1R should exist on airway epithelial cells [14,15,31].”
ResultArakawa, M., Mita, T., Azuma, K., Ebato, C., Goto, H., Nomiyama, T., Fujitani, Y., Hirose, T., Kawamori, R., & Watada, H. (2010) · Diabetes · doi:10.2337/db09-1694 · Cited by 548 · cited 1×
“[24] showed that LPS-induced macrophage activation and TNF-α expression was significantly reduced by”
BackgroundSvegliati‐Baroni, G., Saccomanno, S., Rychlicki, C., Agostinelli, L., De Minicis, S., Candelaresi, C., Faraci, G., Pacetti, D., Vivarelli, M., Nicolini, D., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02462.x · Cited by 405 · cited 1×
“[36] determined that exenatide could ameliorate nonalcoholic fatty liver disease”
BackgroundCampos, R. V. (1994) · Endocrinology · doi:10.1210/en.134.5.2156 · Cited by 353 · cited 1×
“Therefore, these findings, in consistent with the previous studies, indicated that GLP-1R should exist on airway epithelial cells [14,15,31].”
ResultcAMP regulation of airway smooth muscle function
Billington, C. K., Ojo, O. O., Penn, R. B., & Ito, S. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.05.007 · Cited by 240
Bao, Z., Guan, S., Cheng, C., Wu, S., Wong, S. H., Kemeny, D. M., Leung, B. P., & Wong, W. S. F. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1516oc · Cited by 226 · cited 2×
“A number of studies proved that macrophages, neutrophils, eosinophils, and lymphocytes were the mainly immunological cells in airway inflammation in asthma [4,8,26].”
BackgroundAbdelsalam, R. M., & Safar, M. M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13087 · Cited by 221 · cited 1×
“The amount of data also confirmed that PKA was essential for the modulation of NF-κB activation [28,51].”
BackgroundAndrographolide Protects against LPS-Induced Acute Lung Injury by Inactivation of NF-κB
Zhu, T., Wang, D.-X., Zhang, W., Liao, X.-Q., Guan, X., Bo, H., Sun, J.-Y., Huang, N.-W., He, J., Zhang, Y.-K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056407 · Cited by 210 · cited 1×
“Simultaneously, many studies determined that the de novo synthesis of TNF-α and E-selectin, the critical inflammatory molecules, were mainly regulated by NF-κB activation in ARDS and asthma [27,52,53].”
BackgroundSelf-citationGolpon, H. A., Puechner, A., Welte, T., Wichert, P. V., & Feddersen, C. O. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00300-7 · Cited by 158
Seufert, J., & Gallwitz, B. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12251 · Cited by 156 · cited 5×
“GLP-1, a peptide hormone mainly synthetized and secreted by L-cells in guts, is essential for the regulation of glycometabolism.”
BackgroundInfluentialGLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery
Richter, G., Feddersen, O., Wagner, U., Barth, P., Goke, R., & Goke, B. (1993) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1993.265.4.l374 · Cited by 146
Mata, M. (2005) · Thorax · doi:10.1136/thx.2004.025692 · Cited by 137 · cited 1×
“Furthermore, phosphodiesterase 4 (PDE4) inhibitors, such as roflumilast, which can inhibit the degradation of cAMP to increase the phosphorylation of PKA in cells, has been widely used in the treatment of COPD and asthma in clinic recently [44,45] and it is well-known that the main therapeutic effects of β2 receptor a…”
BackgroundViby, N.-E., Isidor, M. S., Buggeskov, K. B., Poulsen, S. S., Hansen, J. B., & Kissow, H. (2013) · Endocrinology · doi:10.1210/en.2013-1666 · Cited by 133 · cited 3×
“[18] also determined that GLP-1R agonists could improve pulmonary function and survival rates of obstructive lung disease in mice.”
BackgroundInfluentialRefractory asthma: mechanisms, targets, and therapy
Trevor, J. L., & Deshane, J. S. (2014) · Allergy · doi:10.1111/all.12412 · Cited by 130 · cited 2×
“Several studies figured out that the majority of airways of fatal asthmatic individuals were blocked by the gelatinous substance composed of mucus and inflammatory exudates [4,6,7].”
BackgroundWang, Y., Parlevliet, E. T., Geerling, J. J., van der Tuin, S. J. L., Zhang, H., Bieghs, V, Jawad, A. H. M., Shiri‐Sverdlov, R., Bot, I., de Jager, S. C. A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12490 · Cited by 126 · cited 1×
“[35] showed that exendin-4 could improve dyslipidaemia and attenuate atherosclerotic lesion severity and area by reducing macrophage recruitment and activation in female APOE*3-Leiden.”
BackgroundDai, Y., Dai, D., Wang, X., Ding, Z., & Mehta, J. L. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6539-4 · Cited by 116
GLP-1 based therapeutics: simultaneously combating T2DM and obesity
Heppner, K. M., & Perez-Tilve, D. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00092 · Cited by 115 · cited 6×
“GLP-1, a peptide hormone mainly synthetized and secreted by L-cells in guts, is essential for the regulation of glycometabolism.”
BackgroundInfluentialSteven, S., Hausding, M., Kröller-Schön, S., Mader, M., Mikhed, Y., Stamm, P., Zinßius, E., Pfeffer, A., Welschof, P., Agdauletova, S., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0465-x · Cited by 114
Kodera, R., Shikata, K., Takatsuka, T., Oda, K., Miyamoto, S., Kajitani, N., Hirota, D., Ono, T., Usui, H. K., & Makino, H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.049 · Cited by 101
Emodin Ameliorates LPS-Induced Acute Lung Injury, Involving the Inactivation of NF-κB in Mice
Xiao, M., Zhu, T., Zhang, W., Wang, T., Shen, Y., Wan, Q.-F., & Wen, F. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151119355 · Cited by 97 · cited 3×
“According to our previous studies, the mRNA expression levels of E-selectin and MUC5AC were detected by qPCR [27,48].”
BackgroundMethodSelf-citationRoflumilast attenuates allergen-induced inflammation in mild asthmatic subjects
Gauvreau, G. M., Boulet, L., Schmid-Wirlitsch, C., Côté, J., Duong, M. T., Killian, K. J., Milot, J., Deschesnes, F., Strinich, T. X., Watson, R. M., et al. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-140 · Cited by 95 · cited 1×
“Furthermore, phosphodiesterase 4 (PDE4) inhibitors, such as roflumilast, which can inhibit the degradation of cAMP to increase the phosphorylation of PKA in cells, has been widely used in the treatment of COPD and asthma in clinic recently [44,45] and it is well-known that the main therapeutic effects of β2 receptor a…”
Backgroundβ-Agonist-mediated Relaxation of Airway Smooth Muscle Is Protein Kinase A-dependent
Morgan, S. J., Deshpande, D. A., Tiegs, B. C., Misior, A. M., Yan, H., Hershfeld, A. V., Rich, T. C., Panettieri, R. A., An, S. S., & Penn, R. B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.557652 · Cited by 89 · cited 1×
“Furthermore, phosphodiesterase 4 (PDE4) inhibitors, such as roflumilast, which can inhibit the degradation of cAMP to increase the phosphorylation of PKA in cells, has been widely used in the treatment of COPD and asthma in clinic recently [44,45] and it is well-known that the main therapeutic effects of β2 receptor a…”
BackgroundChang, M., Chen, C., Chen, Y.-C., Wu, Y., Zhen, Y., Leu, S., Tsai, T., Ko, S.-F., Sung, P., Yang, C.-C., et al. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.98 · Cited by 75
Li, J., Luo, L., Wang, X., Liao, B., & Li, G. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.49 · Cited by 70 · cited 1×
“Simultaneously, many studies determined that the de novo synthesis of TNF-α and E-selectin, the critical inflammatory molecules, were mainly regulated by NF-κB activation in ARDS and asthma [27,52,53].”
BackgroundAnti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury
Higashijima, Y., Tanaka, T., Yamaguchi, J., Tanaka, S., & Nangaku, M. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00590.2014 · Cited by 69
GOU, S., ZHU, T., WANG, W., XIAO, M., WANG, X.-C., & CHEN, Z.-H. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.07.010 · Cited by 66 · cited 1×
“According to our previous studies, the mRNA expression levels of E-selectin and MUC5AC were detected by qPCR [27,48].”
MethodSelf-citationZhao, L., Li, A. Q., Zhou, T. F., Zhang, M. Q., & Qin, X. M. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00151.2014 · Cited by 61 · cited 1×
“Furthermore, several recent studies determined that the bio-active and pharmacological effects of GLP-1 analogs and DPP-4 inhibitors mainly resulted from the activation of a PKA-dependent signaling pathway [20,22,23].”
BackgroundRegulation of IL-4 Receptor Signaling by STUB1 in Lung Inflammation
Wei, Q., Sha, Y., Bhattacharya, A., Fattah, E. A., Bonilla, D., Jyothula, S. S. S. K., Pandit, L., Khurana Hershey, G. K., & Eissa, N. T. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201305-0874oc · Cited by 61 · cited 1×
“Furthermore, several reports showed that Th2 cytokines, particularly IL-4 and IL-13, laid at the center of the recruitment of eosinophils and promoting goblet cell metaplasia and hyperplasia, leading to airway mucus hyper-secretion in asthma [25,37,38].”
BackgroundCyclic AMP concentrations in dendritic cells induce and regulate Th2 immunity and allergic asthma
Lee, J., Kim, T. H., Murray, F., Li, X., Choi, S. S., Broide, D. H., Corr, M., Lee, J., Webster, N. J. G., Insel, P. A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417972112 · Cited by 58 · cited 1×
“Asthma, a common chronic airway disease and featured with reversible airflow obstruction, was caused by the airway allergic reaction with the characteristics of a Th2-predominant airway inflammation [3,8,29].”
BackgroundNebulized Anti–IL-13 Monoclonal Antibody Fab′ Fragment Reduces Allergen-Induced Asthma
Hacha, J., Tomlinson, K., Maertens, L., Paulissen, G., Rocks, N., Foidart, J.-M., Noel, A., Palframan, R., Gueders, M., & Cataldo, D. D. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0031oc · Cited by 57 · cited 1×
“Furthermore, several reports showed that Th2 cytokines, particularly IL-4 and IL-13, laid at the center of the recruitment of eosinophils and promoting goblet cell metaplasia and hyperplasia, leading to airway mucus hyper-secretion in asthma [25,37,38].”
BackgroundGlucagon-like Peptide-1(7–36) Amide Stimulates Surfactant Secretion in Human Type II Pneumocytes
VARA, E., ARIAS-DÍAZ, J., GARCIA, C., BALIBREA, J. L., & BLÁZQUEZ, E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.4.9912132 · Cited by 56
Protective Role of Andrographolide in Bleomycin-Induced Pulmonary Fibrosis in Mice
Zhu, T., Zhang, W., Xiao, M., Chen, H., & Jin, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141223581 · Cited by 54 · cited 2×
“NF-κB p65 DNA-binding activity was analyzed by TransAMTM NF-κB p65 Chemi Transcription Factor Assay kit (Active Motif, Carlsbad, CA, USA) in our study [54,55].”
BackgroundMethodSelf-citationGlucagon-like peptide-1 inhibits angiotensin II-induced mesangial cell damage via protein kinase A
Ishibashi, Y., Matsui, T., Ojima, A., Nishino, Y., Nakashima, S., Maeda, S., & Yamagishi, S. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.06.008 · Cited by 53
Emerging targets for novel therapy of asthma
Gerthoffer, W. T., Solway, J., & Camoretti-Mercado, B. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.04.002 · Cited by 52
Romaní-Pérez, M., Outeiriño-Iglesias, V., Gil-Lozano, M., González-Matías, L. C., Mallo, F., & Vigo, E. (2013) · Endocrinology · doi:10.1210/en.2012-1786 · Cited by 51
Novel cAMP signalling paradigms: therapeutic implications for airway disease
Billington, C. K., & Hall, I. P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01719.x · Cited by 50
Severe refractory asthma: an update
Wener, R. R. L., & Bel, E. H. (2013) · European Respiratory Review · doi:10.1183/09059180.00001913 · Cited by 48 · cited 2×
“Several studies figured out that the majority of airways of fatal asthmatic individuals were blocked by the gelatinous substance composed of mucus and inflammatory exudates [4,6,7].”
BackgroundLiou, C.-J., Cheng, P.-Y., Huang, W.-C., Chan, C.-C., Chen, M.-C., Kuo, M.-L., & Shen, J.-J. (2014) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2014.6.6.548 · Cited by 46 · cited 4×
“leukotrienes (LTs), IL-4, IL-5, and IL-13, which are synthesized and released by inflammatory cells, including macrophages, eosinophils, mast cells, and Th2 cells [3,4,8].”
BackgroundInfluentialBenito, E., Blázquez, E., & Bosch, M. A. (1998) · Endocrinology · doi:10.1210/en.139.5.2363 · Cited by 45
Chang, S., Kim, D., Ryu, G. R., Ko, S., Jeong, I., Ahn, Y., Jo, Y., & Kim, M. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24425 · Cited by 44
GLP-1 Agonists Inhibit ox-LDL Uptake in Macrophages by Activating Protein Kinase A
Dai, Y., Dai, D., Wang, X., Ding, Z., Li, C., & Mehta, J. L. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000087 · Cited by 44 · cited 2×
“[20] found that liraglutide could noticeably suppress macrophages ox-LDL uptake by inactivation of PKA in vitro.”
BackgroundAirway Remodeling: A Comparison Between Fatal and Nonfatal Asthma
Chen, F. H., Samson, K. T. R., Miura, K., Ueno, K., Odajima, Y., Shougo, T., Yamaguchi, Y., & Shioda, S. (2004) · Journal of Asthma · doi:10.1081/jas-200026405 · Cited by 42
Sustained Suppression of IL-13 by a Vaccine Attenuates Airway Inflammation and Remodeling in Mice
Ma, Y., Halayko, A. J., Basu, S., Guan, Q., Weiss, C. R., Ma, A. G., HayGlass, K. T., Becker, A. B., Warrington, R., & Peng, Z. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0060oc · Cited by 39 · cited 1×
“Furthermore, several reports showed that Th2 cytokines, particularly IL-4 and IL-13, laid at the center of the recruitment of eosinophils and promoting goblet cell metaplasia and hyperplasia, leading to airway mucus hyper-secretion in asthma [25,37,38].”
BackgroundZhu, T., Zhang, W., Wang, D., Huang, N., Bo, H., Deng, W., & Deng, J. H. (2012) · PubMed · Cited by 35
Self-citationZhu, T., Zhang, W., & Wang, D. (2012) · Injury · doi:10.1016/j.injury.2012.04.004 · Cited by 35 · cited 2×
“NF-κB p65 DNA-binding activity was analyzed by TransAMTM NF-κB p65 Chemi Transcription Factor Assay kit (Active Motif, Carlsbad, CA, USA) in our study [54,55].”
BackgroundMethodSelf-citationWang, L., Liu, Y., Yang, J., Zhao, H., Ke, J., Tian, Q., Zhang, L., Wen, J., Wei, R., & Hong, T. (2014) · Endocrinology · doi:10.1210/en.2014-1218 · Cited by 28 · cited 1×
“Furthermore, several recent studies determined that the bio-active and pharmacological effects of GLP-1 analogs and DPP-4 inhibitors mainly resulted from the activation of a PKA-dependent signaling pathway [20,22,23].”
BackgroundEffects of VIP and Related Peptides on Airway Mucus Secretion from Isolated Rat Trachea
Wagner, U., Bredenbröker, D., Storm, B., Tackenberg, B., Fehmann, H. C., & von Wichert, P. (1998) · Peptides · doi:10.1016/s0196-9781(97)00257-x · Cited by 27 · cited 2×
“Therefore, these findings, in consistent with the previous studies, indicated that GLP-1R should exist on airway epithelial cells [14,15,31].”
BackgroundResultLeaker, B. R., Singh, D., Ali, F. Y., Barnes, P. J., & O'Connor, B. J. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-166 · Cited by 19
Mehal, J. M., Holman, R. C., Steiner, C., Bartholomew, M. L., & Singleton, R. J. (2014) · CHEST Journal · doi:10.1378/chest.14-0183 · Cited by 17 · cited 1×
“According to Global Initiative for Asthma (GINA) guidelines, the prevalence of asthma is estimated to be 1% to 18%, affecting more than 200 million people worldwide [1,2].”
Solubilization of active receptors for glucagon-like peptide-1(7-36)amide from rat lung membranes
Göke, R., Kolligs, F. T., Richter, G., Lankat–Buttgereit, B., & Göke, B. (1993) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1993.264.2.l146 · Cited by 16
Epidemiology of bronchial asthma and asthma control assessment in Henan Province, China
Zhang, W., Chen, X., Ma, L., Wu, J., Zhao, L., Kuang, H., Huang, T., Cheng, J., Zhang, L., Qi, Y., et al. (2014) · Translational Respiratory Medicine · doi:10.1186/2213-0802-2-5 · Cited by 15 · cited 1×
“According to Global Initiative for Asthma (GINA) guidelines, the prevalence of asthma is estimated to be 1% to 18%, affecting more than 200 million people worldwide [1,2].”
Self-citationPKA negatively regulates PP2Cβ to activate NF-κB-mediated inflammatory signaling
Choi, H.-K., Park, S., Oh, H.-J., Han, E.-J., Lee, Y., Lee, J., Jun, W. J., Choi, K., & Yoon, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.129 · Cited by 12 · cited 1×
“The amount of data also confirmed that PKA was essential for the modulation of NF-κB activation [28,51].”
BackgroundA new link to airway obstruction in asthma
Corry, D. B., & Kheradmand, F. (2007) · Nature Medicine · doi:10.1038/nm0707-777 · Cited by 10 · cited 4×
“Asthma is characterized by chronic, persistent airway inflammation and airway remodeling, leading to incompletely-reversible airway obstruction, particularly at late stages [3,4].”
BackgroundInfluentialJing, Li, ‡., Luo, et al. (2009) · 中国免疫学杂志:英文版 · Cited by 9
Cited by
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
Lee, Y.-S., & Jun, H.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3094642 · Cited by 530
Koga, Y., Tsurumaki, H., Aoki‐Saito, H., Sato, M., Yatomi, M., Takehara, K., & Hisada, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061346 · Cited by 165
Emodin suppresses LPS-induced inflammation in RAW264.7 cells through a PPARγ-dependent pathway
Zhu, T., Zhang, W., Feng, S.-J., & Yu, H.-P. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.02.014 · Cited by 141
Self-citationGLP-1 receptor agonist as a modulator of innate immunity
Chen, J., Mei, A., Wei, Y., Li, C., Qian, H., Min, X., Yang, H., Dong, L., Rao, X., & Zhong, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.997578 · Cited by 120
“Frontiers in Immunology 05 showed that GLP-1R signaling inhibits the innate immune response in animal models of asthma, by the activation of PKA/NF-kB signaling pathway (99) and the decreased eosinophil production of IL-4, IL-8 and IL-13 (39).”
BackgroundPradhan, R., Lu, S., Yin, H., Yu, O. H. Y., Ernst, P., Suissa, S., & Azoulay, L. (2022) · BMJ · doi:10.1136/bmj-2022-071380 · Cited by 111
Metadata
- Authors
- Zhu, T., Wu, X.-L., Zhang, W., & Xiao, M.
- Affiliations
- West China Hospital of Sichuan University (CN)
- Department of Respiratory Medicine, and Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, West China Hospital of Sichuan University, Chengdu 610041, China
- First Affiliated Hospital of Chengdu Medical College (CN)
- Corresponding author
- Xiao, Min
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2015-08-26
- Volume
- 16
- Issue
- 9
- Pages
- 20195-20211
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC4613197
- OpenAlex
- W1915288020
- Cited by
- 106
- References
- 58
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 10 · 2023: 10 · 2022: 13 · 2021: 13 · 2020: 11 · 2019: 9 · 2018: 9 · 2017: 5 · 2016: 4
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Applying Fundamental Research Foundation of Sichuan Province of China (2013JY0032)
- China Postdoctoral Science Foundation (2014M552369)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- glucagon-like peptide-1, liraglutide, asthma, airway inflammation, mucus hypersecretion, ovalbumin-induced asthma, protein kinase A, NF-κB signaling, NF-κB p65, E-selectin, MUC5AC, H89, anti-inflammatory therapy
- MeSH terms
- Animals, Asthma, Bronchoalveolar Lavage Fluid, Disease Models, Animal, Leukocyte Count, Leukocytes, Mucus, Ovalbumin, Signal Transduction, Cytokines, NF-kappa B, Cyclic AMP-Dependent Protein Kinases, Inflammation Mediators, E-Selectin, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.